Table 5. Logistic regression analysis for the predictors of high-grade IPC.
IPC, incidental prostate cancer; PSA, prostate-specific antigen; HALP, hemoglobin-albumin-lymphocyte-platelet; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; OR, odds ratio; CI, confidence interval
Variable | High-grade IPC | |||
Univariate | Multivariate | |||
P-value | OR (95% CI) | P-value | OR (95% CI) | |
Age | 0.07 | 1.06 (0.99-1.13) | 0.06 | 1.07 (0.99-1.15) |
PSA | 0.08 | 1.01 (0.99-1.02) | 0.28 | 1.01 (0.99-1.02) |
NLR score | 0.14 | 1.01 (0.99-1.03) | - | - |
PLR score | 0.12 | 1.00 (0.99-1.02) | - | - |
HALP score | <0.001 | 0.92 (0.87-0.96) | 0.004 | 0.92 (0.87-0.97) |
Specimen weight | 0.053 | 0.95 (0.89-1.001) | 0.057 | 0.94 (0.88-1.00) |